Caligan Partners’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$84.5M Hold
1,553,262
3.98% 5
2026
Q1
$66.6M Hold
1,553,262
4.43% 7
2025
Q4
$68.1M Buy
1,553,262
+27,532
+2% +$1.14M 5.6% 7
2025
Q3
$63M Hold
1,525,730
8.25% 4
2025
Q2
$67.2M Hold
1,525,730
12.93% 3
2025
Q1
$56.3M Hold
1,525,730
11.75% 3
2024
Q4
$50.8M Hold
1,525,730
12.87% 3
2024
Q3
$39.6M Hold
1,525,730
12.55% 3
2024
Q2
$34.3M Buy
1,525,730
+425,000
+39% +$9.43M 8.01% 4
2024
Q1
$26.1M Buy
1,100,730
+190,000
+21% +$4.22M 6.9% 5
2023
Q4
$21.8M Hold
910,730
7.37% 4
2023
Q3
$19.9M Hold
910,730
9.14% 6
2023
Q2
$17.4M Buy
910,730
+60,730
+7% +$1.17M 9.79% 3
2023
Q1
$16.5M Buy
+850,000
New +$14.8M 11.51% 4

Other funds holding EXEL

Caligan Partners's EXEL Position: Q2 2026 in Review

Caligan Partners held its Exelixis (EXEL) position steady in Q2 2026 at 1,553,262 shares worth $84.5M. The position accounts for 3.98% of the portfolio, ranked #5.

Caligan Partners first reported a position in EXEL in Q1 2023 and has held it in 14 quarters since. 756 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Caligan Partners held 1,553,262 shares of Exelixis worth $84.5M as of Q2 2026.
  • Caligan Partners left its Exelixis share count unchanged in Q2 2026.
  • Exelixis made up 3.98% of Caligan Partners's portfolio in Q2 2026, its #5 holding.
  • Caligan Partners first reported a position in Exelixis in Q1 2023 and has held it in 14 quarters since.
  • 756 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Caligan Partners's 13F filing for Q2 2026, filed 14 Aug 2026.